Skip to main content
. Author manuscript; available in PMC: 2025 Aug 20.
Published in final edited form as: J Appl Physiol (1985). 2025 Jul 28;139(3):616–627. doi: 10.1152/japplphysiol.00917.2024

Table 2.

Number of participants using the indicated medications (self-reported at screening).

Young Older
5-alpha reductase inhibitor 0 1
ACE inhibitors/ARBs 0 7
Alpha 1 blockers 0 1
Non-tricyclic antidepressants 1 3
Antihistamines 3 2
Aspirin 0 3
Bisphosphonate derivatives 0 2
CNS stimulants 2 0
Non-loop diuretics 0 3
Birth control/estradiol 2 1
Gabapentin 0 2
Inhaled glucocorticoids 0 4
Thyroid drugs 0 1
Proton pump inhibitors 0 2
Semaglutide 0 1
Statins/fibric acid 0 12
Testosterone 0 1
Triptan 1 0
Vitamins 5 7

ACE, Angiotensin converting enzyme; ARB, Angiotensin receptor blocker; CNS, Central nervous system